Trial Profile
Evaluation of the analgesic efficacy and psychoactive effects of AZD1940, a novel peripherally acting cannabinoid agonist, in human capsaicin-induced pain and hyperalgesia
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 24 Oct 2013
Price :
$35
*
At a glance
- Drugs NEO 1940 (Primary)
- Indications Pain
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 31 Aug 2012 New trial record
- 28 Aug 2012 Results presented at the 14th World Congress on Pain.